Exelixis INC.
Based in CA
🤖
AI Overview
With $10.7M in lobbying spend across 31 quarterly filings, Exelixis INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 2 issue areas. Active from 2019 to 2025.
$10.7M
Total Spend
7
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $990K |
| 2020 | $920K |
| 2021 | $950K |
| 2022 | $1.2M |
| 2023 | $1.8M |
| 2024 | $1.8M |
| 2025 | $3.0M |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Taxation
- •Issues relating to pharmaceutical pricing
- •Issues related to pharmaceutical access and pricing.
- •The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019 and issues related to pharmaceutical access and pricing.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.